FDA.reportPublic FDA data

Avalide 300/25 Oral Tablet

RxCUI
823942
RxNorm name
Avalide 300/25 Oral Tablet
Display name
Avalide 300/25 Oral Tablet
Full name
Avalide 300/25 Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c7750b68-b3d8-45fa-b134-bf75f6ac510eAvalide 300 MG / 25 MG Oral Tablet [PSN] · hydrochlorothiazide 25 MG / irbesartan 300 MG Oral Tablet [Avalide] [SBD] · Avalide 300/25 (irbesartan / HCTZ) Oral Tablet [SY] · Avalide 300/25 Oral Tablet [SY] · HCTZ 25 MG / irbesartan 300 MG Oral Tablet [Avalide] [SY]52These highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE (irbesartan and hydrochlorothiazide) tablet for oral use AVALIDE (irbesartan and hydrochlorothiazide) tablet, film coated for oral use Initial U.S. Approval: 199720100119